According to the Greek protocol, prior to radical prostatectomy I underwent:...

May 19, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

According to the Greek protocol, prior to radical prostatectomy I underwent: ________________________________________ WHOLE-BODY BONE SCINTIGRAPHY WITH Tc-99m MDP – [date removed] From the performed skeletal radionuclide study, increased radiotracer uptake is observed in the left temporoparietal region of the skull, with ill-defined margins, a finding that requires targeted radiological correlation for further evaluation. The remainder of the skeleton is unremarkable. Note: Regarding this finding, my physician stated that it does not represent disease. ________________________________________ CT SCAN OF THE UPPER AND LOWER ABDOMEN – [date removed] Sections of 0.75 mm thickness were obtained before and after intravenous administration of iodinated contrast material. A small sliding hiatal hernia is noted, with an anteroposterior diameter of 28 mm. Mild hepatic steatosis is observed. No areas of pathological enhancement are identified within the liver. No radiopaque gallstones are detected, and there is no dilatation of the biliary tree. The portal vein is patent. The pancreas and spleen demonstrate normal morphology and size, without focal lesions. No dilatation of the main pancreatic duct is observed. Mild adenomatous hyperplasia of the adrenal glands. Renal cystic lesions are present, with the largest located in the left kidney measuring 16 mm in diameter. No evidence of obstructive uropathy. Atherosclerotic changes of the abdominal aorta and its branches are noted. The infrarenal segment of the abdominal aorta measures 28 mm in diameter. A small paraumbilical fat-containing hernia of approximately 10 mm is observed. No enlarged abdominal lymph nodes are identified, nor is there evidence of ascites. Incomplete filling of the urinary bladder. Heterogeneity of the density of the prostate gland. Seminal vesicles are symmetrical. Degenerative changes of the lumbosacral spine are noted. Heterogeneity of bone density is observed, requiring overall comparative evaluation with scintigraphy. ________________________________________ CONCLUSION: Hepatic steatosis. Hiatal hernia. Adenomatous hyperplasia of the adrenal glands. Renal cystic lesions. Ectasia of the infrarenal abdominal aorta. Paraumbilical fat-containing hernia. Heterogeneity of the prostate gland and of bone density.

Understanding Your Pre-Surgical Staging Workup

Thank you for sharing these important staging studies. Let me help you understand what these tests show and how they relate to your prostate cancer treatment planning.


What These Tests Were Checking

Before radical prostatectomy (surgical removal of the prostate), your doctors ordered staging studies to answer critical questions:

  1. Has the cancer spread to bones? (Bone scintigraphy)
  2. Are there lymph node metastases or distant spread? (CT abdomen/pelvis)
  3. Is your body healthy enough for surgery? (Overall assessment)

According to NCCN Guidelines for Prostate Cancer, staging imaging is recommended for intermediate-risk and higher-risk patients to rule out metastatic disease before treatment planning.


Your Bone Scintigraphy Results ([date removed])

What the Test Does:

A bone scan uses a radioactive tracer (Tc-99m MDP) that accumulates in areas of bone with high metabolic activity. Cancer that has spread to bone typically shows increased uptake.

Your Finding:

  • Increased uptake in left temporoparietal skull region (back-upper area of skull)
  • Ill-defined margins (not a sharp, clear boundary)
  • Remainder of skeleton: unremarkable (normal)

What Your Physician Said:

"This does not represent disease" — This is the key clinical interpretation.

Why This Matters:

The increased uptake in your skull could represent several benign conditions:

  • Degenerative changes (normal wear and tear)
  • Old trauma or healed injury
  • Benign bone lesion
  • Artifact (technical issue with the scan)

The fact that:

  • ✅ It's isolated to one area
  • ✅ It has ill-defined margins (not the sharp pattern typical of cancer)
  • ✅ The rest of your skeleton is normal
  • ✅ Your physician explicitly stated it's not disease

...suggests this is a benign finding that does not change your cancer staging.


Your CT Scan Results ([date removed])

This is a detailed cross-sectional imaging study of your abdomen and pelvis. Let me break down what was found:

GOOD NEWS — Cancer-Related Findings:

| Finding | What It Means | |---------|---------------| | No enlarged lymph nodes | ✅ No evidence of cancer spread to regional lymph nodes | | No ascites | ✅ No fluid in abdomen (sign of advanced disease) | | Seminal vesicles symmetrical | ✅ No obvious invasion of seminal vesicles | | No distant metastases | ✅ No evidence of spread to liver, pancreas, or other organs |

This is reassuring for your staging.

INCIDENTAL FINDINGS — Not Related to Your Cancer:

These are unrelated medical findings that your radiologist noted:

| Finding | Significance | |---------|--------------| | Hepatic steatosis | Fatty liver (common, usually benign; may warrant lifestyle modification) | | Hiatal hernia (28 mm) | Small hernia where stomach protrudes through diaphragm (common, usually asymptomatic) | | Adrenal adenomatous hyperplasia | Benign enlargement of adrenal glands (very common, not cancer) | | Renal cystic lesions (largest 16 mm) | Simple kidney cysts (extremely common, benign) | | Aortic ectasia (28 mm) | Mild widening of abdominal aorta (related to atherosclerosis; requires monitoring) | | Paraumbilical fat hernia (10 mm) | Small hernia near belly button (benign) | | Degenerative spine changes | Normal age-related wear and tear |

None of these findings change your prostate cancer treatment plan.


What About the "Heterogeneity" Findings?

The report mentions:

  • "Heterogeneity of the density of the prostate gland"
  • "Heterogeneity of bone density"

Prostate Heterogeneity:

This refers to uneven density within the prostate gland itself—consistent with your known cancer and benign prostatic tissue. This is expected given your biopsy-proven cancer and doesn't change staging.

Bone Density Heterogeneity:

The report notes this requires "comparative evaluation with scintigraphy." This likely refers to the skull finding mentioned in the bone scan. Your physician's interpretation that it's benign addresses this concern.


Your Overall Staging Summary

Based on these studies:

| Staging Component | Finding | |------------------|---------| | Primary Tumor (T) | T1c (found on biopsy, not palpable) | | Regional Lymph Nodes (N) | N0 (no lymph node involvement) | | Distant Metastases (M) | M0 (no distant spread) | | Overall Stage | Stage I-II (Localized Disease) |

This is the best possible staging for someone with your cancer diagnosis.


What This Means for Your Radical Prostatectomy

According to NCCN Guidelines, your staging workup shows:

No evidence of metastatic disease — Surgery is appropriate

Cancer is localized to the prostate — Radical prostatectomy can be curative

No lymph node involvement — Extended pelvic lymph node dissection may not be necessary (your surgeon will decide)

No contraindications to surgery — Your incidental findings don't prevent surgery


Important Considerations Before Surgery

Your CT scan identified some findings that your surgical team should know about:

1. Aortic Ectasia (28 mm infrarenal aorta)

  • What it is: Mild widening of the main blood vessel in your abdomen
  • Why it matters: Your surgeon needs to know this to avoid vascular injury during surgery
  • Action: Make sure your surgical team has reviewed this finding

2. Hepatic Steatosis (Fatty Liver)

  • What it is: Fat accumulation in liver (common with age, obesity, metabolic syndrome)
  • Why it matters: May affect anesthesia metabolism; not a contraindication to surgery
  • Action: Mention to your anesthesiologist

3. Hiatal Hernia

  • What it is: Small hernia where stomach protrudes through diaphragm
  • Why it matters: May increase reflux risk; inform anesthesia team
  • Action: Mention to your anesthesiologist

Questions to Ask Your Surgical Team Before Radical Prostatectomy

  1. "My staging workup shows no lymph node involvement or distant metastases. Does this mean I don't need extended pelvic lymph node dissection, or will you still perform it?"

  2. "My CT scan shows mild aortic ectasia (28 mm infrarenal aorta). How does this affect your surgical approach?"

  3. "I have a hiatal hernia and fatty liver noted on CT. Do these findings affect anesthesia or surgical planning?"

  4. "My bone scan showed an uptake in the skull that my physician said doesn't represent disease. Do you agree with that interpretation?"

  5. "What is your plan for the seminal vesicles—will you remove them, and does my staging suggest they're involved?"

  6. "What is your expected operative time, blood loss, and hospital stay for my procedure?"

  7. "What are the main risks of radical prostatectomy, and how do you manage them?"

  8. "Will you perform nerve-sparing surgery, and what are my chances of preserving erectile function?"


Key Takeaway

Your staging workup is reassuring:

No evidence of cancer spread — Your cancer appears localized to the prostate

No lymph node involvement — No regional spread

No distant metastases — No spread to bones, organs, or other sites

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: